PART1 and esophageal squamous cell carcinoma: LncRNA prostatic androgen-regulated transcription 1 (PART1) was transmitted by exosomes and taken by recipient cells, inducing resistance to gefitinib in esophageal squamous cell carcinoma (ESCC)[11].